Like I said before
1)Ath has to get a biotech name for their drug from the WHO
2) Drug manufacture in the US
3) FDA … accelerated approval..
4)Partner … a) Distribution
. b) continuation Phase 3
All takes time….
I see no problems now that we have approx $51 million in the BANk..
With a MC over $100 million
Greatest risk of AD is poor control of ferroptosis, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.001(6.67%) |
Mkt cap ! $147.3M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.7¢ | 1.5¢ | $770.2K | 49.71M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2038332 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 349000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |